The week at Retraction Watch featured a study suggesting that 2% of studies in eight medical journals contained suspect data, and the announcement of a retraction on a professor’s blog. Here’s what was happening elsewhere: Two companies whose stocks plummeted after a Nature Methods study claimed CRISPR introduced unexpected mutations want the study retracted because of alleged … Continue reading Weekend reads: A demand for a CRISPR paper retraction; a weak data-sharing policy; can we trust journals?